B

BioPorto Diagnostics A/S

45 employees

BioPorto Diagnostics offers a wide range of diagnostic tests and antibodies to healthcare professionals in clinical and research settings.

Basic info

Industry

biotechnology research

Sectors

NGAL biomarker
Biotechnology
NGAL ELISA kits (human and animal
Acute kidney injury (AKI) biomarker
generic Rapid Assay Device (gRAD)
Antibodies
Clinical research
Lateral flow assay development (gRAD)
scientific and pre-clinical drug research
pre-clinical
Health Diagnostics
Appetite Regulating Hormones
diagnostics
Health Care
non-clinical research
clinical research
drug induced kidney injury (DIKI)
Assay Development
In-vitro Diagnostics (IVD)
Complement and Innate Immunity
FDA Qualified Biomarker (BQP)
research & development

Date founded

1995

FAQ